ATE202382T1 - Multifaktorielles abwehr-modulatorengemisch, verfahren zu seiner herstellung und diese modulatoren enthaltende arzneimittel - Google Patents

Multifaktorielles abwehr-modulatorengemisch, verfahren zu seiner herstellung und diese modulatoren enthaltende arzneimittel

Info

Publication number
ATE202382T1
ATE202382T1 AT96907302T AT96907302T ATE202382T1 AT E202382 T1 ATE202382 T1 AT E202382T1 AT 96907302 T AT96907302 T AT 96907302T AT 96907302 T AT96907302 T AT 96907302T AT E202382 T1 ATE202382 T1 AT E202382T1
Authority
AT
Austria
Prior art keywords
production
modulators
multifactory
products containing
medicinal products
Prior art date
Application number
AT96907302T
Other languages
English (en)
Inventor
Hans-Werner Heinrich
Udo Meyer
Volker Bange
Egon Tech
Original Assignee
Privates Inst Bioserv Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Privates Inst Bioserv Gmbh filed Critical Privates Inst Bioserv Gmbh
Application granted granted Critical
Publication of ATE202382T1 publication Critical patent/ATE202382T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96907302T 1995-03-24 1996-03-21 Multifaktorielles abwehr-modulatorengemisch, verfahren zu seiner herstellung und diese modulatoren enthaltende arzneimittel ATE202382T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19512227A DE19512227C1 (de) 1995-03-24 1995-03-24 Multifaktorielles Abwehr-Modulatorengemisch, Verfahren zu seiner Herstellung und diese Modulatoren enthaltende Arzneimittel
PCT/DE1996/000550 WO1996030537A1 (de) 1995-03-24 1996-03-21 Multifaktorielles abwehr-modulatorengemisch, verfahren zu seiner herstellung und diese modulatoren enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
ATE202382T1 true ATE202382T1 (de) 2001-07-15

Family

ID=7758518

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96907302T ATE202382T1 (de) 1995-03-24 1996-03-21 Multifaktorielles abwehr-modulatorengemisch, verfahren zu seiner herstellung und diese modulatoren enthaltende arzneimittel

Country Status (4)

Country Link
EP (1) EP0815253B1 (de)
AT (1) ATE202382T1 (de)
DE (1) DE19512227C1 (de)
WO (1) WO1996030537A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10107731A1 (de) * 2001-02-16 2002-09-05 Karl Hecht Verwendung eines polyfunktionellen Wirkstoffgemisches als Tabakrauchschadstoffantagonist als gesundheitsschützendes Mittel beim Tabakrauchen
DE102006051941A1 (de) * 2006-01-24 2007-07-26 Egon Tech Multifunktionales Wirkstoffgemisch
DE202007007542U1 (de) * 2007-05-26 2007-10-04 Tech, Egon Aminosäure-Mineral-Peptid-Komplex, insbesondere quantenmechanisch modifiziert, als Arzneimittel zur Behandlung von Demenzerkrankungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3504940C2 (de) * 1984-02-17 1997-11-06 Bayer Ag Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel

Also Published As

Publication number Publication date
WO1996030537A1 (de) 1996-10-03
DE19512227C1 (de) 1996-10-31
EP0815253A1 (de) 1998-01-07
EP0815253B1 (de) 2001-06-20

Similar Documents

Publication Publication Date Title
ATE15798T1 (de) Heterozyklische carboxamide, zubereitungen, die solche verbindungen enthalten, verfahren zu ihrer herstellung und methoden zur behandlung damit.
ATE180408T1 (de) Herstellung eines arzneimittels zur behandlung von augenentzündung durch blockierung von zelladhäsionsmolekulen
MY113045A (en) Waste treatment plant and process
ATE140918T1 (de) Derivate in der vitamin d-reihe mit modifikationen in der 20 position, verfahren zu ihrer herstellung, zwischenprodukte für dieses verfahren, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln
ATE48602T1 (de) Beta-carboline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE69325393D1 (de) Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen
ATE74791T1 (de) Verfahren und vorrichtung zur biologischen reinigung von abgas.
Newman Selective blockade of human natural killer cells by a monoclonal antibody.
ATE242316T1 (de) Neurale transplantation durch verwendung von pluripotenten neuroepithelzellen
DE3683678D1 (de) Verfahren zur herstellung von nuetzlichen hochmolekulargewichtssubstanzen durch kultur von vermehrungsfaehigen tierzellen und dazu geeignetes kultursystem.
DE69634510D1 (de) Streptococcus toxinmutanten und verfahren zu deren anwendung
ATE135359T1 (de) Sulfoniumsalze und verfahren zu deren herstellung
KR880014109A (ko) 암-관련 항원-특이적 인간 면역 글로불린 및 인간 면역 글로불린 을 생산하는 능력을 갖는 인간/인간 하이브리도마
ATE202382T1 (de) Multifaktorielles abwehr-modulatorengemisch, verfahren zu seiner herstellung und diese modulatoren enthaltende arzneimittel
ATE45879T1 (de) Regelverfahren fuer mikroflora und zusammensetzungen dazu.
DE69735439D1 (de) Mutanten von streptococcaltoxin c und verfahren zu deren anwendung
ATE346860T1 (de) Mutanten von streptococcaltoxinen und vefahren zu deren anwendung
FR2763335B1 (fr) Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2373544A1 (fr) Nouveaux 7-o-alkylnogarols, leur procede de preparation et medicaments les contenant
DK0852623T3 (da) Nukleinsyremolekyler kodende for proteiner, som medierer adhæsionen af Neisseria-celler til humane celler
RU94035727A (ru) Способ утилизации отравляющих веществ группы люизита, иприта и их смесей
ATE65778T1 (de) 4-oxo-thiazolidin-2-yliden-acetamid-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel zur bekaempfung von erkrankungen des zentralnervensystems.
SE8500102L (sv) Forfarande for mikrofloraavlossning
PT83368A (en) Process for propagating microorganisms in vivo by using cell lines which lack human class ii histocompatibility antigens
DE69627121D1 (de) Chemische modifikation von teilchenförmigen reagenzien nach ihrer synthese

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee